Case File
efta-efta01788848DOJ Data Set 10CorrespondenceEFTA Document EFTA01788848
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01788848
Pages
0
Persons
0
Integrity
No Hash Available
Loading PDF viewer...
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Sent:
Sunday, April 7, 2013 5:19 PM
To:
Jeffrey Epstein
Subject:
*Confidential: Re: Model Scenarios - Confidential
Hi Jeffrey,
The founders received a debt financed distribution of $1B from AMH in 2007 (44% to Leon and 28% to each of Marc and
Josh). They didn't have any tax basis in their AMH interests at the time; however, the new debt was allocated to them,
which resulted in a $1B of tax basis in their AMH partnership interests that allowed them to receive the distribution tax-
free. This $1B is the Tufts gain - a gain that will be recognized as AMH liabilities are no longer allocated to the founders.
20% of those liabilities shifted away from the founders to APOC in 2007 at the time of the 2007 sale, and the founders
recognized 20% of their Tufts gain (5200M in total) in 2007. That left 80% of each founder's Tufts gain (5800M in total)
remaining. Absent a guarantee, the Tufts gain will get triggered ratably as the founders exchange APP interests for AGM
units. Let me know if you want to discuss in more detail. Thanks,
Brian
Brian Knudson I Partner I National Tax - Partnership and Joint Ventures
Ernst & Young LIP
200 South Sixth Street Suite 1400, Minneapolis, Minnesota 55402 United States of America
Office
Mobile:
I
<mailto
Website: www.ey.com
Assistant: Lenora Wold I Phone:
I
<mailto
Thank you for
considering the environmental impact of printing emails.
From: Jeffrey Epstein <[email protected]>
To:
04/07/2013 11:32 AM
Subject:
Re: Model Scenarios - Confidential
how is the tuft gain ccalculated
On Sat, Apr 6, 2013 at 11:54 PM,
<mailtc
> wrote:
Hi Jeffrey,
EFTA_R1_00113833
EFTA01788848
At Patrick Fenn's request, we're attaching .pdf versions of the full models that we have run for Patrick using discount
rates of 2%, 5% and 7.5%. Each version is in a separate .pdf file. Please note that in each case, the presentation (the first
9 pages of each file) refer to a 7.5% discount rate; however, the actual discount rate used in each scenario is in the name
of each file, as well as the input sheet on page 10 of each file and the detailed model pages that follow in pages 11
through 24.
As a policy, our firm does not provide "live" versions of Excel models to clients without specific waivers being executed.
We do this because we cannot guarantee that changes made to the inputs of the model or formulas within the model
will produce the correct result without a detailed review. Thus, we generally provide the outputs of our models in pdf
format. Alternatively, if you would like to review the model in more detail, and be able to see the formulas and cell
references within the model, we can provide you with a "locked" or password-protected version of each model. These
versions would allow you to open the model in Excel and see cell contents, formulas, and references; however, the
contents of each cell could not be altered.
We hope that the attached will provide you with the detail that you need for your analysis. In the event that you desire
locked versions of the models (or additional scenarios), please let me know and I can get them to you as soon as
possible. Best regards,
Brian
Brian Knudson I Partner I National Tax - Partnership and Joint Ventures Ernst & Young LLP
200 South Sixth Street, Suite 1400, Minneapolis, Minnesota 55402, United States of America
Office:
Mobile:
<te
I
<mailto
Website: www.ey.com <http: www.ey.com >
Assistant: Lenora Wold I Phone: +
<mailto
<tele.
I
Thank you for considering
e erivffom
rierM
rr
la impac o printing emails.
Any U.S. tax advice contained in the body of this e-mail was not intended or written to be used, and cannot be used, by
the recipient for the purpose of avoiding penalties that may be imposed under the Internal Revenue Code or applicable
state or local tax law provisions.
The information contained in this message may be privileged and confidential and protected from disclosure. If the
reader of this message is not the intended recipient, or an employee or agent responsible for delivering this message to
the intended recipient, you are hereby notified that any dissemination, distribution or copying of this communication is
strictly prohibited. If you have received this communication in error, please notify us immediately by replying to the
message and deleting it from your computer.
Notice required by law: This e-mail may constitute an advertisement or solicitation under U.S. law, if its primary purpose
is to advertise or promote a commercial product or service. You may choose not to receive advertising and promotional
messages from Ernst & Young LIP (except for Ernst & Young Online and the ey.com <http://ey.com/> website, which
track e-mail preferences through a separate process) at this e-mail address by forwarding this message to no-more-
[email protected] <mailto:[email protected]> . If you do so, the sender of this message will be notified promptly. Our
principal postal address is 5 Times Square, New York, NY 10036. Thank you. Ernst & Young LLP
2
EFTA_R1_00113834
EFTA01788849
The information contained in this communication is confidential, may be attorney-client privileged, may constitute
inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized
use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you
have received this communication in error, please notify us immediately by return e-mail or by e-mail to
[email protected] <mailto:[email protected]> , and destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
Any U.S. tax advice contained in the body of this e-mail was not intended or written to be used, and cannot be used, by
the recipient for the purpose of avoiding penalties that may be imposed under the Internal Revenue Code or applicable
state or local tax law provisions.
The information contained in this message may be privileged and confidential and protected from disclosure. If the
reader of this message is not the intended recipient, or an employee or agent responsible for delivering this message to
the intended recipient, you are hereby notified that any dissemination, distribution or copying of this communication is
strictly prohibited. If you have received this communication in error, please notify us immediately by replying to the
message and deleting it from your computer.
Notice required by law: This e-mail may constitute an advertisement or solicitation under U.S. law, if its primary purpose
is to advertise or promote a commercial product or service. You may choose not to receive advertising and promotional
messages from Ernst & Young RP (except for Ernst & Young Online and the ey.com website, which track e-mail
preferences through a separate process) at this e-mail address by forwarding this message to [email protected]. If
you do so, the sender of this message will be notified promptly. Our principal postal address is 5 Times Square, New
York, NY 10036. Thank you. Ernst & Young LIP
3
EFTA_R1_00113835
EFTA01788850
Technical Artifacts (6)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
www.ey.comEmail
[email protected]Email
[email protected]Email
[email protected]URL
http://ey.comWire Ref
referencesRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.